A case report highlights the response to Sotorasib in a patient with recurrent KRAS G12C-mutated low-grade serous ovarian cancer. This study contributes to the understanding of targeted therapies for this specific mutation.
response to sotorasib in a patient with recurrent kras g12c mutated low grade serous ovarian cancer a case report and literature review
Original title: “Response to Sotorasib in a patient with recurrent KRAS G12C-mutated low-grade serous ovarian cancer: a case report and literature review.”